These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4280498)

  • 21. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms.
    Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT
    Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Practolol.
    Galbraith JE
    Med J Aust; 1975 May; 1(21):664. PubMed ID: 1152725
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug eruptions caused by beta-blockers].
    Bonnetblanc JM
    Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ; Beeley L
    Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A patient with skin eruptions due to practolol].
    Faber WR; Hulsebosch HJ; Overdijk AD; van der Upwich WG
    Ned Tijdschr Geneeskd; 1976 Jan; 120(4):165-7. PubMed ID: 128703
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse reaction to the beta-adrenergic blocking drugs.
    Brigden WD; Almeyda J
    Br J Dermatol; 1976 Sep; 95(3):335-8. PubMed ID: 974021
    [No Abstract]   [Full Text] [Related]  

  • 27. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Practolol reaction.
    Benny PS; Denham HE; Panting AL
    N Z Med J; 1975 Jul; 82(544):62-3. PubMed ID: 1058342
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sclerosing peritonitis and practolol (author's transl)].
    Hess T; Stucki P
    Med Klin; 1977 Jul; 72(28-29):1220-4. PubMed ID: 887049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerosing peritonitis with short-term propranolol therapy.
    Nicholls JT; Rutty DA
    Arch Intern Med; 1980 Aug; 140(8):1124-5. PubMed ID: 6446892
    [No Abstract]   [Full Text] [Related]  

  • 31. Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin).
    Sondergaard J; Wadskov S; Jensen HA; Mikkelsen HI
    Acta Derm Venereol; 1976; 56(3):239-43. PubMed ID: 59510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular disorders resulting from treatment with practolol (Eraldin) [proceedings].
    Cruysberg JR; Pinckers A
    Ophthalmologica; 1977; 175(1):39-40. PubMed ID: 904900
    [No Abstract]   [Full Text] [Related]  

  • 33. Practolol peritonitis with autopsy findings.
    Hayton AC
    N Z Med J; 1978 Mar; 87(607):177-9. PubMed ID: 274658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
    Wright P
    Br Med J; 1975 Mar; 1(5958):595-8. PubMed ID: 1125623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Sclerosing peritonitis and practolol.
    Lancet; 1975 Feb; 1(7901):275-6. PubMed ID: 46416
    [No Abstract]   [Full Text] [Related]  

  • 36. [Complications in treatment with beta blockader Practolol (Eraldin)].
    Brinck HP; Aasved H; Jacobsen KB
    Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1357-9, 1352. PubMed ID: 126503
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Practolol and sclerosing peritonitis.
    Meyboom RH
    Lancet; 1975 Feb; 1(7902):334-5. PubMed ID: 46476
    [No Abstract]   [Full Text] [Related]  

  • 38. An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1211-6. PubMed ID: 17853493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Delayed fibrinous peritonitis after practolol treatment.
    Allan D; Cade D
    Br Med J; 1975 Oct; 4(5987):40. PubMed ID: 1174917
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
    Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E
    Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.